Angioplasty Balloons Market: Preference for Drug-coated Balloons Increasing at a Rapid Rate

Balloon Angioplasty is used to open constricted and blocked arteries. The angioplasty balloon is inflated many times to press the blocking plaque towards the wall of the arteries in order to create a broader passage area for blood flow. Demand for angioplasty balloons market has witnessed significant growth owing to the increased incidences of cardiovascular diseases that have shaped as major reason behind fatalities across the globe. Balloon angioplasty is even employed for critical cardiovascular conditions which increases its demand, thereby propelling the global angioplasty balloon market.

Cutting balloons are losing significance

Global angioplasty balloons market can be segmented majorly into Normal balloons, drug coated balloons, scoring balloons and cutting balloons, amongst which drug-coated angioplasty balloons are the ones that have gained significance in recent years. They are popular for their multiple health benefits like greater safety, higher effectiveness and improved blood flow that benefits the medical outcome. A Fact.MR report analyzed the historical data to predict the growth of drug-coated balloons segment to be very fast and is expected to attain a growth rate of   ̴4% CAGR in the year 2020.

Cutting balloons were preferred over normal balloons at the time of their introduction in market. But over time, its popularity and demand has declined. Many factors like presence of better alternatives, device stiffness and risks of complex lesions are collaboratively responsible for the deteriorating market presence of cutting balloons.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4318

Average selling price of angioplasty balloons has gone down in recent years and is restraining the growth of global angioplasty balloons market. It also negatively impacts the overall revenue generated by the market. Manufacturers and major players are taking help of technology to strengthen their presence and gain profit. They are inculcating technology in their products to speed up in order to suffice the growing demand. Technology laden products also go in-tune with the trending culture of value-based health care. Manufacturers are altering the important ingredients of these balloons to create new products. They have changed material and operational procedures to launch new products in market that impart greater benefits to the patient.

Europe and North America Lead

The leading regions with largest global angioplasty balloons market are Europe and North America. Both the regions are experiencing growing awareness regarding treatment option and general health which diverts the population towards balloon angioplasty. Presence of established market players in the region along with adoption of advanced technology in medical sector are the other major factors that work in favor of Europe and North America’s market dominance. Fact.MR report suggests that both the regions will continue to maintain their dominance in the global market.

Countries in APAC like India, Japan, China and Australia have emerged as lucrative market in angioplasty balloons landscape. They are anticipated to grow at    ̴5% CAGR rate for the forecast period 2020-2025. Improvement in health care infrastructure, growing awareness about Percutaneous Coronary Intervention procedures and cost effective treatment are the factors that drive the angioplasty balloons market in APAC. Manufacturers are diverting their attention towards APAC to attract customers in this region.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4318

Cardiovascular Emergencies and Ageing Population is Leveraging the Use of Ambulance Services

Fact.MR published a report on the ambulance cots market that includes the global industry analysis 2014 – 2018 and forecast 2019 – 2029. The ambulance cots market report projects that the ambulance cots market is expected to reach ~ US$ 223 Mn by the end of 2019 in terms of value, and is estimated to reach ~ US$ 273 Mn by the end of 2029.

Launch of New Ambulance Services and New Opportunities in Developing Countries

There are several air ambulance services and other innovative types of ambulances that are developed in the emergency medical service industry that utilize pneumatic ambulance cots or electric ambulance cots. For instance, in India, motorbike ambulances were launched in Delhi in 2017 and Mumbai in 2018. Similarly, in the U.S., Malley Industries, a supplier of New Brunswick's ambulances, expanded its fleet into the U.S. market in 2016 with electric and pneumatic ambulance cots. Several private ambulance service providers offer air ambulance services across the world that use electric or pneumatic ambulance cots. The trend of adopting air ambulances in both developed and developing regions is expected to positively influence the growth of the ambulance cots market during the forecast period. According to WHO, 1 ambulance per 50,000 population is a standard that a country should have or aim to reach, in order to meet the growing demand. However, in Nanjing, China, there are only 50 ambulances for a population of 8 million in 2013. Thus, there is a requirement for more ambulances in the APAC region, which is an opportunity for the ambulance cots market in the region.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4166

Rising Installed Base of Ambulances offer Significant Growth Opportunities

According to the WHO and several scientists, the minimum number of ambulances required is estimated to be one in 50,000 population across the world. Some countries exceed the number of minimum ambulance requirement norms. To meet the rising incidence of emergencies across the globe and to reduce the duration of response, more ambulances are required. Most countries, such as the U.S., the U.K., and Germany, have ambulances more than the required norms and yet are facing several conditions, such as delay in response, unequal distribution of ambulances in urban and rural areas, and increasing emergencies. This results in an increased demand for ambulance services in these regions that influence the growth of the ambulance cots market. Some countries, such as Singapore and Burma (Myanmar), have ambulances below the required norms. The number of ambulances needed in Burma is around 1149. However, the country recently launched its first ambulance service in 2015 and has only 230 ambulances in its fleet. Other countries, such as Indonesia, have slightly more ambulances than the required norms, and still faces similar problems as those with insufficient ambulances. Thus rising number of ambulances in both the developed and developing nations drive the growth of the ambulance cots market.

Rising Number of Accidents Increasing the Usage of Ambulances – A Key Influencer

According to the World Bank data, 1.3 million people are killed in road accidents every year. Furthermore, there are about 30 million people that are seriously impacted by injuries caused by road traffic. Number of people injured, along with the number of deaths due to road accidents, are factors that are used to assess the number of road accidents. This excludes suicide involving the use of road motor vehicles. In 2014, it was assessed that 22% of GDP per capita in Thailand was associated with deaths and injuries due to the road traffic. India and China also estimated that 14% and 15% respectively of the GDP per capita was associated with road accidents. According to a survey in India, in 2016, a total of 480,652 road accidents occurred that resulted in the death of 150,785 and 494,624 people with serious injuries. The rising proportion of vehicles and accidents are leading to the increasing use of emergency services, such as ambulance, which is expected to drive the growth of the ambulance cots market.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4166

Key Manufacturers of Ambulance Cots

Stryker Corporation and Ferno-Washington Inc. are the prominent players in the ambulance cots market. Other players in the ambulance cots market are Zhangjiagang New Fellow Med Co. Ltd., Jiangsu Rixin Medical Equipment Co. Ltd., Jiangsu Saikang Medical Equipment Co. Ltd., Dragon Industry (ZJG) Co., Ltd., Omega Surgical Industries, and Paramed International FZ Co., among others.

Prostate Cancer Diagnostics Market: Focus on Hospital Labs and Research Institutes

According to the latest report by Fact.MR, the global prostate cancer diagnostics market is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn. In this prostate cancer diagnostics market study, the following years are considered to predict the market footprint:

• History Year: 2012-2016


• Base Year: 2012


• Estimated Year: 2022


• Forecast Year: 2017 – 2022

The business intelligence study of the prostate cancer diagnostics market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the prostate cancer diagnostics market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the prostate cancer diagnostics market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:

• North America (U.S., Canada)


• Latin America (Brazil, Mexico)


• Europe (France, Spain)


• APEJ (China, India)


• MEA (South Africa, Nigeria)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=58

The key players in the global prostate cancer diagnostics market report consist of

• Biocept, Inc


• Agilent Technologies


• Myriad Genetics Inc


• Cancer Genetics, Inc


• Foundation Medicine, Inc.


• Becton, Dickinson and Company


• Danaher Corporation


• Bayer Aktiengesellschaft


• AstraZeneca plc


• Abbott Laboratories

Each market player encompassed in the prostate cancer diagnostics market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the prostate cancer diagnostics market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.

On the basis of end user, the global prostate cancer diagnostics market report covers the footprint, and consumption of the segments including

• Hospital Associated Labs


• Independent Diagnostic Laboratories


• Cancer Research Institutes

The global prostate cancer diagnostics market covers the demand trends of each test type which includes

• PSA Tests


• CTC Tests


• Immunohistochemistry


• PCA3 test

What insights readers can gather from the prostate cancer diagnostics market report?

• A critical study of the prostate cancer diagnostics market on the basis of test type, end user and region.


• Learn the behavior pattern of every prostate cancer diagnostics market player – product launches, expansions, collaborations and acquisitions in the market currently.


• Examine and study the progress outlook of the global prostate cancer diagnostics market landscape, which includes, revenue, production & consumption and historical & forecast.


• Understand important drivers, restraints, opportunities, and trends (DROT Analysis).


• Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.

The prostate cancer diagnostics market report answers the following queries:

1. Which players hold the significant prostate cancer diagnostics market share and why?


2. What strategies are the prostate cancer diagnostics market players forming to gain a competitive edge?


3. Why region is expected to lead the global prostate cancer diagnostics market?


4. What factors are negatively affecting the prostate cancer diagnostics market growth?


5. What will be the value of the global prostate cancer diagnostics market by the end of 2022?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Why Choose Fact.MR?

1. Deliver updated information on the current industry trends


2. Available 24/7 to facilitate clients with unbiased solutions


3. Embrace digital technologies to offer accurate business ideas


4. Exhaustive supply chain augmentation analysis


5. Provide reports strictly according to the requirements of the clients

Benzodiazepine Drugs Market to See Upturn Growth during 2020 -2026

Global Benzodiazepine Drugs Market - A Report by Fact.MR

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global benzodiazepine drugs market. The benzodiazepine drugs market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the benzodiazepine drugs market report elaborates the market behavior of each vendor operating in the benzodiazepine drugs market.

The benzodiazepine drugs market report considers the following years to present the overall market growth:

• Estimated Year: 2026


• Forecast Year: 2020 – 2026

Key findings of the benzodiazepine drugs market study:

• Regional breakdown of the benzodiazepine drugs market based on predefined taxonomy.


• Innovative manufacturing processes implemented by benzodiazepine drugs market vendors in detail.


• Region-wise and country-wise fragmentation of the benzodiazepine drugs market to grasp the revenue, and growth outlook in these areas.


• Changing preferences among consumers across various regions and countries.


• Factors (Positive and Negative) impacting the growth of the global benzodiazepine drugs market.

On the basis of product, the benzodiazepine drugs market study consists of:

• Alprazolam


• Clonazepam


• Diazepam


• Lorazepam

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4432

On the basis of application, the benzodiazepine drugs market study incorporates:

• Anxiety


• Insomnia


• Alcohol Withdrawal


• Seizures

On the basis of region, the benzodiazepine drugs market study contains:

• North America (U.S., Canada)


• Europe (U.K., France)


• Asia Pacific (China, India)


• Latin America (Brazil, Mexico)

Key players analyzed in the benzodiazepine drugs market study:

• Pfizer Inc.


• Hoffmann-La Roche Ltd.


• Bausch Health Companies, Inc.


• Mylan N.V.


• Teva Pharmaceutical Industries Ltd.


• Lundbeck A/S


• Amneal Pharmaceuticals LLC


• Sun Pharmaceutical Industries Ltd.


• Apotex Inc.


• Aurobindo Pharma

Queries addressed in the benzodiazepine drugs market report:

• Why are the benzodiazepine drugs market players targeting region for increased product sales?


• What patented technologies are the players utilizing in the global benzodiazepine drugs market?


• Which regions are displaying the fastest growth in the benzodiazepine drugs market?


• What are the underlying micro- macroeconomic factors affecting the global benzodiazepine drugs market?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Introduction of Non-surgical Treatments to Propel BCC Treatment Market at 9% CAGR

Basal cell carcinoma is one of the most common types of skin cancers observed around the world. Conventionally, the disease has been treated with procedures such as standard surgical excisions, and curettage. The risk of contracting the disease increases among people who have immunosuppression issues, fair skin, genetic disorders, exposure to ultraviolet light, and a history of BCC.

The global basal cell carcinoma treatment market is projected to grow at an impressive CAGR of 9 per cent through the forecast period till 2025. This growth can be attributed to the increased investments being made by healthcare and pharmaceutical industries into the development of better drug formulations, with the aim of cutting down the risk of basal cell carcinoma.

Increased Use of Contract Research Organizations and Radiotherapy Gain Traction

Countries in the Asia Pacific and North America regions are expected to display a high potential for growth for the basal cell carcinoma treatment market, which can be attributed to the rising patient awareness about the ailment and the recent advancements and growing range of treatment options including Mohs micrographic surgery, superficial field therapies, and electrodessication.

In addition, a number of contract research organizations such as the Skin Cancer Foundation have come up, which have been pushing to increase awareness about the cancer, while also creating training programs for health care professionals for the correct implementation of new treatment options.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4366

Further, countries in the Asia Pacific region are expected to generate substantial revenue generation opportunities, in comparison numerous regions in such treatment markets on a global scale. Contract research organizations are also providing new information and insight on treatments such as radiotherapy, which is substantially influencing the landscape of the market.

Non-invasive Treatments are Major Contributors

While surgical treatments have been the most popular conventionally, patients are increasingly preferring to opt for non-invasive treatments such as superficial radiation therapy (SRT) as such treatment results in lesser risk of complications.

In addition, delays in treating basal cell carcinoma can result in issues with bone, skin, and muscle damage, which has also contributed to the increased adoption of SRT over the increasingly impractical practice of radiotherapy.

In addition, the older conventional methods and machines of SRT has become obsolete, and create challenges in terms of operations and maintenance. Consequently, modernization of these equipment is working as a catalyst to the growth of the global basal cell carcinoma market.

SRT has been found to result in better outcomes for the patients, as treatments can only impact cancer cells, leaving healthy cells unaffected. Consequently, the rate of adoption has also gone up in terms of specialty clinics and hospitals. In addition, such equipment also finds roles in treating squamous cell carcinoma as well, increasing demand.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4366